Introduction
Recombinant Human Calprotectin (S100A8/S100A9) Protein, also known as MRP8/14 or S100A8/A9, is a heterodimeric protein complex composed of two subunits, S100A8 and S100A9. It belongs to the S100 family of calcium-binding proteins and is found in various tissues and cells, including neutrophils, monocytes, and epithelial cells. This protein has been extensively studied for its role in inflammation and is considered an important biomarker in various diseases. In this article, we will discuss the structure, activity, and applications of Recombinant Human Calprotectin Protein.
Structure of Recombinant Human Calprotectin Protein
The structure of Recombinant Human Calprotectin Protein is composed of two subunits, S100A8 and S100A9, which are joined together by a disulfide bond. Each subunit is approximately 10 kDa in size and contains two calcium-binding EF-hand domains. The calcium-binding sites are essential for the biological activity of the protein. The complex has a molecular weight of approximately 22 kDa and a pI of 6.5.
Activity of Recombinant Human Calprotectin Protein
Recombinant Human Calprotectin Protein has been shown to have a wide range of activities, including antimicrobial, anti-inflammatory, and immunomodulatory effects. It is primarily released by neutrophils and monocytes in response to inflammatory stimuli and acts as a damage-associated molecular pattern (DAMP) molecule. It binds to various receptors, including Toll-like receptor 4 (TLR4), receptor for advanced glycation end products (RAGE), and CD36, to initiate an inflammatory response.
One of the most well-studied activities of Recombinant Human Calprotectin Protein is its antimicrobial effect. It has been shown to inhibit the growth of various bacteria, fungi, and viruses. This is achieved through multiple mechanisms, including chelation of essential metal ions, disruption of bacterial membranes, and induction of oxidative stress. It also has a role in modulating the immune response to infection, by recruiting immune cells and promoting the production of cytokines and chemokines.
Applications of Recombinant Human Calprotectin Protein
Recombinant Human Calprotectin Protein has a wide range of applications in both research and clinical settings. Its role as a biomarker for inflammation has been extensively studied, and it has been found to be elevated in various diseases, including inflammatory bowel disease, rheumatoid arthritis, and sepsis. Measurement of calprotectin levels in body fluids, such as blood, urine, and stool, can provide valuable information about the extent and severity of inflammation.
In addition to its use as a biomarker, Recombinant Human Calprotectin Protein has also been investigated as a potential therapeutic agent. Its antimicrobial and anti-inflammatory properties make it a promising candidate for the treatment of infectious and inflammatory diseases. It has been shown to have a protective effect in animal models of sepsis and colitis, and clinical trials are currently underway to evaluate its efficacy in these conditions.
Another potential application of Recombinant Human Calprotectin Protein is in the development of diagnostic assays. Its specific binding to receptors, such as TLR4 and RAGE, makes it a potential target for the detection of inflammatory conditions. This could lead to the development of rapid and sensitive diagnostic tests for various diseases.
Conclusion
In summary, Recombinant Human Calprotectin Protein is a heterodimeric protein complex with a wide range of activities and applications. Its structure, composed of two subunits with calcium-binding EF-hand domains, is essential for its biological function. It has been extensively studied for its role in inflammation and has potential applications in biomarker discovery, therapeutic development, and diagnostic assays. Further research on this protein is needed to fully understand its mechanisms of action and to explore its potential in various disease states.
There are no reviews yet.